With no upgradation plan, several small drug companies may shut operations

​Only a fraction of such units, 1,700 out of an estimated 6,000, have submitted plans for upgradation as per the newly-notified Good Manufacturing Practices (GMP), people in the know told ET.

Leave a Comment

Leave a Reply

Your email address will not be published. Required fields are marked *